Podcast Episode 125: Young-Onset Parkinson’s Disease: Lifestyle, Family, and Counseling

PD Library thumbnail

Parkinson’s disease (PD) does not exclusively affect the older population. In fact, about four percent of people with PD in the United States developed the disease before age 50. This is called Young-Onset Parkinson’s disease (YOPD). While the disease in younger people resembles in many ways PD in the older age group, it presents some unique challenges, including issues with employment, sexuality, pregnancy, family life, financial planning and parenting. In this episode, the second of two on YOPD, Dr. Bart Post of Radboud University in Nijmegen, the Netherlands, a Parkinson’s Foundation Center of Excellence, focuses on some of the social and interpersonal issues, including work, family, and women’s issues. He also describes the Phase of Life Dependent Support Program that he has developed at his university to meet the special needs of people with YOPD.

Download This Episode


Related Resources

About This Episode

Released: March 22, 2022

Bart Post, MD

Bart Post, MD

Bart Post, MD was born on March 30, 1972 in Grootebroek, the Netherlands. He obtained his medical degree in 1999 at the University of Maastricht (with honors). In 2000, he started his training as a resident in Neurology at the Academic Medical Centre in Amsterdam, which he completed in December 2008. In 2002, he started a research project on ‘Prognosis in Parkinson’s disease’ that resulted in a PhD thesis in 2009. In 2006, he started a master of Sciences (MSc) education in clinical epidemiology at the EMGO institute in Amsterdam.

In 2009, Dr. Post was certified as a clinical epidemiologist. Since 2010, he has been working as a movement disorder neurologist in the Parkinson Centre in the Radboudumc in Nijmegen (head: prof. dr. B. Bloem). He is part of the steering committee of several large Parkinson trials: the LEAP-trial (Early administration of levodopa in de novo PD); and the CHEVAL-trial (administration of acetylcholine inhibitors in PD patients with hallucinations) and the Fair-Park trial (Iron chelation in early Parkinson’s Disease).

Within the Movement Disorders he is a member of the Multiple System Atrophy (MSA) Study Group. Dr. Post has organized several masterclasses on parkinsonism and movement disorders in the Netherlands. He is a member of the examinations committee of the Dutch neurology Society. He is also a member of two Dutch guideline committees: 1. guideline diagnosis and management of Parkinson’s disease 2. guideline diagnosis and management atypical parkinsonism. In 2018 he was a visiting member of the movement disorders group of Victor Fung in Sydney, Australia.

At the department of neurology of the Radboudumc, he is chair of the residency program for neurologists and, in the Radboudumc, he is co-chair of the central committee for residency programs. Dr. Post is co-director of the Parkinson Foundation Center of Excellence Radboudumc, Nijmegen, the Netherlands. He has a special interest in patients living with Parkinson’s disease at a young age and is heading a program of co-creating care for this patient group.

Want More?

Don't forget to subscribe! There are many ways to listen: Apple PodcastsGoogle PlayTuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)

For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.


Sign Up for Our E-Newsletter

Get the latest news about PD research, resources and community initiatives – straight to your inbox.

Please enter a valid email

Skip step

Invalid year format. Eg: 2020
Skip step
Zip code is required for chapter communications
Skip step

*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.